GIANNONE, FERDINANDO ANTONINO
 Distribuzione geografica
Continente #
NA - Nord America 1.763
EU - Europa 1.106
AS - Asia 699
AF - Africa 58
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.631
Nazione #
US - Stati Uniti d'America 1.757
GB - Regno Unito 300
VN - Vietnam 241
CN - Cina 197
IT - Italia 189
SE - Svezia 171
SG - Singapore 152
DE - Germania 124
IN - India 61
CH - Svizzera 54
IE - Irlanda 52
RU - Federazione Russa 44
UA - Ucraina 39
FR - Francia 35
TG - Togo 27
EE - Estonia 22
JO - Giordania 22
ZA - Sudafrica 22
BG - Bulgaria 21
BE - Belgio 15
FI - Finlandia 14
IR - Iran 12
HR - Croazia 8
CA - Canada 6
CI - Costa d'Avorio 6
NL - Olanda 5
AT - Austria 4
GR - Grecia 3
HK - Hong Kong 3
ID - Indonesia 3
JP - Giappone 3
BR - Brasile 2
ES - Italia 2
NG - Nigeria 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
CL - Cile 1
IL - Israele 1
KG - Kirghizistan 1
LB - Libano 1
NO - Norvegia 1
SC - Seychelles 1
SI - Slovenia 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 3.631
Città #
Southend 274
Fairfield 223
Chandler 189
Dong Ket 165
Singapore 135
Ashburn 130
Woodbridge 127
Wilmington 99
Seattle 97
Cambridge 94
Houston 88
Santa Clara 75
Bologna 73
Ann Arbor 72
Princeton 62
Dublin 52
Bern 48
Boardman 36
Lomé 27
Westminster 27
Nanjing 24
Amman 22
Padova 22
San Diego 20
Sofia 20
Shenyang 19
Milan 18
Jacksonville 17
Jinan 17
Turin 16
Berlin 15
New York 14
Beijing 13
Helsinki 13
Bremen 12
Hebei 12
Brussels 11
Redmond 11
Saint Petersburg 11
Florence 10
Changsha 8
Tianjin 8
Abidjan 6
Ardabil 6
Des Moines 6
Nanchang 6
Ningbo 6
Shanghai 6
Chicago 5
Guangzhou 5
Jiaxing 5
Los Angeles 5
Olalla 5
Redwood City 5
Amsterdam 4
Antwerp 4
Dearborn 4
Mountain View 4
Mülheim 4
Norwalk 4
Zhengzhou 4
Haikou 3
Hong Kong 3
Hyderabad 3
Jakarta 3
Lausanne 3
Medford 3
San Jose 3
Shenzhen 3
Taizhou 3
Toronto 3
Aachen 2
Abeokuta 2
Barcelona 2
Bühl 2
Dallas 2
Esslingen am Neckar 2
Fuzhou 2
Hangzhou 2
Kuban 2
Kunming 2
Lanzhou 2
London 2
Moscow 2
Ottawa 2
Paris 2
Phoenix 2
San Francisco 2
São Paulo 2
Vercelli 2
Verona 2
Vienna 2
Zanjan 2
Andover 1
Azor 1
Bangkok 1
Baoding 1
Baranzate 1
Bishkek 1
Casamassima 1
Totale 2.601
Nome #
A novel model of CCl4-induced cirrosi with ascites in the mouse. 186
Albumin homodimers in patients with cirrhosis: clinical and prognostic relevance of a novel identified structural alteration of the molecule. 183
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 178
Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate 165
Androgen receptor expression in the human vagina under different physiological and treatment conditions 156
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischemia-reperfusion injury complicated by endotoxemia. 149
A fast and validated mass spectrometry method for the evalutation of human serum albumin structural modifications in the clinical field. 148
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 148
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury. 144
Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis. 143
An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury 139
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 135
Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer. 128
Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. 127
The analysis of food intake in patients with cirrhosis waiting for liver transplantation: A neglected step in the nutritional assessment 126
Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases. 124
The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma 123
Posttranscriptional changes of serum albumin: clinical and prognostic meaning in hospitalized patients with cirrhosis. 120
Endocannabinoids and endocannabinoid-related molecules in patients with liver cirrhosis 118
Molecular and functional characterization of CD133+stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells 117
What is the best fruit juice to use as a negative oral contrast agent in magnetic resonance cholangiopancreatography? 112
The role of the endocannabinoid system in liver diseases. 107
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 105
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis. 104
Effetto dell’antagonismo farmacologico dei recettori per gli endocannabinoidi sull’equilibrio idrosodico nella cirrosi epatica. Prospettive terapeutiche. [Effect of the pharmacological antagonism of the endocannabinoid receptors on the sodium balance in liver cirrhosis] 99
Portal hypertension and liver cirrhosis in rats: effect of the beta3-adrenoceptor agonist SR58611A. 94
Reversal of liver fibrosis by the antagonism of endocannabinoid CB1-receptor in a rat model of CCl4-induced advanced cirrhosis. 92
Response to The reduced CO2+ -binding ability of ischaemia-modified albumin is unlikely to be because of oxidative modification of the N-terminus" 87
Adjuvant beverage - Valutazione della distensione intestinale, preliminare alla Entero-RM, mediante un prodotto naturale 73
Totale 3.730
Categoria #
all - tutte 9.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.106


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020602 0 0 0 0 0 86 114 115 136 68 31 52
2020/2021552 85 34 4 21 9 37 15 26 41 23 28 229
2021/2022705 91 17 46 75 45 27 22 60 18 42 168 94
2022/2023727 73 106 50 88 48 58 12 26 115 21 56 74
2023/2024217 25 33 6 35 16 35 16 7 5 10 20 9
2024/2025403 37 113 52 51 124 26 0 0 0 0 0 0
Totale 3.730